Last month, the U.S. Pain Foundation rallied a total of 761 pain warriors nationwide to urge Congress to allocate funding for the Pain Management Best Practices Interagency Task Force report, a federal blueprint for improving pain care. Cindy Steinberg, National Director of Advocacy and Policy, served on the task force that developed the report.
Through U.S. Pain’s action campaign, 738 individuals sent 2,452 emails to Congress, and 71 individuals made 167 calls. Meanwhile, the hashtag #aplanforpain was tweeted out roughly 1,000 times across social media platforms. People from across 49 states and D.C. participated (if you live in South Dakota, or know someone who does, please join the campaign!).
Throughout June as National Headache and Migraine Awareness Month (MHAM), the U.S. Pain Foundation and fellow patient organizations focused their efforts on educating patients and the public about the realities of life with headache diseases. (And even though it’s July, there are still a few opportunities to learn and take action!)
Launch of the INvisible Project: Migraine & Headache 4th Edition
The month kicked off with multiple launch parties for the newest edition of the INvisible Project, which highlights 10 patients and families coping with varying types of headache diseases ranging from cluster headache to new daily persistent headache. You can download the full PDF of the magazine or order print copies, free of charge, by visiting the INvisible Project website.
June is Migraine and Headache Awareness Month (#MHAM)! A large percentage of our community lives with migraine and headache diseases, whether as the primary cause of their pain or a comorbidity.
Nationwide, headache and migraine diseases affect 47 million Americans. Despite their huge impact, these conditions are often overlooked and downplayed as “It’s just a headache.”
But we know it is far more than simply head pain. Headache and migraine diseases are complex, debilitating, and symptoms can affect your entire body.
Thank you. You created the groundswell we needed to start getting Congress to pay attention to the “Pain Management Best Practices” report.
During our Virtual Advocacy campaign, 595 pain warriors sent 1,944 emails to Congress. 60 pain warriors made 144 calls to Congress. And #aplanforpain was tweeted out at least 500 times, reaching thousands of people, including federal legislators.
We’re dedicating today, June 11, to flooding policymakers with our request that they allocate funding for key recommendations in the “Pain Management Best Practices” report–a roadmap for improving pain care nationwide.
At U.S. Pain Foundation, we believe this report has the power to revolutionize pain care in the United States. But nothing will change for pain warriors unless Congress hears from YOU. Taking action is fast, fun, and incredibly important to improving the lives of the 50 million Americans with chronic pain.
City and State: Easton, MA
Pain Warrior Role: U.S. Pain advocate since 2011.
Health Conditions: I live with chronic widespread pain due to lupus and chronic pelvic pain due to endometriosis.
Favorite Tip For Those Living With Pain: “Take time every single day to remind yourself that you are a strong, brave, unique, and amazing person, who is always worthy of being treated with respect and dignity. Also, never let yourself forget that you possess an intrinsic value that exists just from you being you, and having chronic pain can never negate nor diminish this.”
As part of its “Action Collaborative on Countering the U.S. Opioid Epidemic,” the National Academy of Medicine (NAM) recently hosted a listening session to better understand the experiences of people living with chronic, non-cancer pain, including their experiences interacting with and navigating the health system. NAM also is seeking patients to share their experiences online via this survey.
Volunteers are the heart and soul of the U.S. Pain Foundation. No matter what your interests are, or what your physical limitations may be, there is an opportunity for you to make a difference. The majority of our volunteer activities can be done from the comfort of home!
Below is a list of examples of ways to get involved, and information on how to get started. If you’d like to get more information on opportunities to act straight to your inbox, sign up as a volunteer here.
Buy Tetracycline Online
Although antibiotics are sometimes used to treat bacterial infections, they can be effective against other kinds of infections as well, e.g. viral infections, fungal infections (especially yeast), viruses, bacterial pneumonia, and viruses of the central nervous system. They can be useful to treat other pathogenic infections as well, e.g. infectious diseases, inflammatory disorders, and other conditions of inflammation and inflammation-related diseases (especially non-inflammatory conditions such as fibrosis). Such medication is usually administered with a diet rich in foods rich in micronutrients and phytochemicals (tannins) found in the plants, fruits and fungi of the plants. Because an antimicrobial agent stimulates growth of bacterial cells or bacteria, it can cause or alleviate symptoms, while a conventional therapy, which uses the usual antibiotics to treat conditions that are related to an infection, is highly ineffective. (Oxycycline is used primarily to treat Lyme disease). The efficacy of many of the antibiotics used in the medical therapy of the common cold (ie, azithromycin, cefomyces cefotaxime and tetracycline) is inversely related to their potency against other classes of bacteria. The lower potency of the antibiotic used for treating influenza may be associated with the higher cost of antibiotics for treating other diseases. (Sertraline is a common antihistamine used in the treatment of the cold) In contrast to the typical case of a single antibiotic, one of the major differences between bacteriophages and bacteriocis infections is the distribution of antibiotic resistance genes. Bacteriology can be described as any group of organisms in which the presence or disappearance of antibiotic resistance genes results in a reduced ability of the organism to cause an infection by other bacteria. There are three main classes of antibiotic resistance genes: the dominant type, a subtype, and an orphan type genes that are found within each antibiotic-resistance gene. The dominant-type genes are used in many forms such as, but are not limited to, antibiotics, fungicides and antimicrobial agents. The subtype-resistance genes are found on an increased frequency among certain strains of yeasts (proteobacteria), on certain types of viruses (the enteroviruses), and on all of the bacteria found in the human environment. Antibiotics are highly resistant bacterial species, as most species naturally express certain mutations in antibiotic resistance genes. A bacteriophage is a bacteriocide that is used to attack bacteria. There are approximately one million types of bacteriophages that are used by humans; only a few of these are specific bacteria, https://tabl1.com/. However, because of the resistance of bacteria and many instances of antibiotic resistance with many species, there is considerable concern for the safety of bacterial infections. Most infections will kill bacteria but some will not. Thus, bacteriophages are considered potentially dangerous for humans. A bacteriophage is used to control pathogenic microbes that exist in a host’s environment and (The drugs used at first seem less effective than after some time). An experimental treatment may be administered when it is believed that an unusual reaction is causing the illness. The drug is administered in very large amounts as a dose or a dose at once. Other methods of administration used for experimental treatment include intravenous (IV) injection of a live bacterial antiserum (also known as a fluoroquinolone, penicillin, or ciprofloxacin), or needle aspiration of a live organism from an infected wound.
By Elisa Friedlander, LMFT
Recently, during a dinner outing with my wife and another couple, I mentioned my plan to try driving again (it’s been several years since disabling neck pain and other medical problems made driving a thing of the past). One friend responded, “Great! You can finally be independent!” There was no ill-intention in her comment. Still, it felt like an eyelash jabbing my cornea. At the time, I just nodded. My “response” came later that evening when I was alone in my head: